The World's Biggest Health Issue
Cardiovascular disease is the leading cause of death worldwide, responsible for 44,000 deaths annually in Australia and 20 million globally.
80% of these deaths are preventable with early intervention and broader, more accurate screening.
Mass Population Screening -
No Blood Tests Required
CardiAction is designed for large-scale, mass-population screening, eliminating the need for a cholesterol blood test while maintaining high accuracy.
Our unique biomarker algorithm detects Cardiovascular Event Risk with approximately 80% accuracy, validated by independent research.
Breaking Barriers for
Vulnerable Communities
CardiAction brings critical screening to Indigenous populations and low socioeconomic groups, where access to traditional healthcare is often limited due to cultural, financial or geographical barriers.
The screening is non-invasive and does not require blood tests, making it culturally appropriate and accessible to underserved populations.
Accessible Online
Cardiovascular Event Risk Assessment
Easily accessible directly by patient online, making early detection and preventative action possible for large populations, including those in remote or underserved areas.
Patients receive a personalised Cardiovascular Event Risk Indicator with advice on the next steps to confirm and manage their risk.
Backed by Research
CardiAction's model is supported by independent studies and proven as a reliable predictor of cardiovascular event risk in mass screening programs, particularly benefiting communities with restricted access to healthcare.
Contact Us
©2024 All Rights Reserved
